Mutations, drugs drive cancer by blurring growth signals
Saturday, September 1, 2018 - 10:54
in Biology & Nature
Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study. The research could have important implications for understanding and ultimately targeting the defective mechanisms underlying many human cancers.